Pharmacy Practice Faculty Publications

Recent publications

• A call for student pharmacist education on vaping and vaping device use March 1, 2021
  INTRODUCTION: The use of vaping devices, including e-cigarettes, has been steadily increasing in recent years, especially among younger populations.
  Katherine M Marti
• Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin February 27, 2021
  CONCLUSIONS: In nonvalvular atrial fibrillation patients with type 2 diabetes, rivaroxaban was associated with an ~ 10% relative reduction in vascular mortality and fewer bleeding-related hospitalizations versus warfarin.
  Craig I Coleman
• Air Medical Transport of Patients Diagnosed With Confirmed Coronavirus Disease 2019 Infection Undergoing Extracorporeal Membrane Oxygenation: A Case Review and Lessons Learned February 27, 2021
  The coronavirus disease 2019 pandemic disrupted health care delivery in every respect, including critical care resources and the transport of patients requiring extracorporeal membrane oxygenation. Innovative solutions allowing for safe helicopter air transport of these critical patients is needed because extracorporeal membrane oxygenation resources are only available in specialty centers. We present a case demonstrating […]
  Thomas Bascetta
• The authors reply February 22, 2021
  No abstract
  Aaron Shoskes
• Survey of Pharmacists' Knowledge of Connecticut's Medical Cannabis Program February 22, 2021
  Introduction: Over the last few years, a growth in research and interest in medical cannabis (most often referred to as medical marijuana) use have occurred nationally. Medical cannabis has become a treatment option for disease conditions, such as epilepsy, wasting syndrome associated with AIDs, and post-traumatic stress disorder, when traditional medication is ineffective. Objectives: The […]
  Sara Mandy Reece
• Influence of digoxin on mortality in patients with atrial fibrillation: Overview of systematic reviews February 5, 2021
  Once a routine part of atrial fibrillation (AF) management, digoxin use has declined. Likely hastening this decline are findings from several studies and systematic reviews identifying a potential association between digoxin use and all-cause mortality in AF populations. However, inconsistency exists within some of these studies potentially leading to confusion among clinicians. To critically evaluate […]
  William L Baker
• Ranitidine's N-nitrosodimethylamine Problem May be Tip of the Iceberg January 29, 2021
  No abstract
  C Michael White
• Response to Cottu, Bozec, Basse, and Paoletti January 6, 2021
  No abstract
  Hua Zhang
• Pharmacist Identification of Medication Therapy Problems Involving Cognition Among Older Adults Followed by a Home-Based Care Team December 23, 2020
  CONCLUSIONS: Our study findings support the role of pharmacists on multidisciplinary teams to identify cognitively harmful medications, dementia treatment side effects, and untreated cognitive conditions.
  Allison M P Levine
• Author Correction: Roadmap for naming uncultivated Archaea and Bacteria November 13, 2020
  No abstract
  Alison E Murray
• Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose September 22, 2020
  CONCLUSIONS: Hydroxychloroquine is a generally well-tolerated medication. Short-term (days to weeks) toxicity includes gastrointestinal effects and rarely glucose abnormalities, dermatologic reactions, and neuropsychiatric events. Cardiotoxicity became of increased concern with its use in COVID-19 patients. Long-term (years) toxicities include retinopathy, neuromyotoxicity, and cardiotoxicity (conduction abnormalities, cardiomyopathy). Deaths from overdoses most often result from cardiovascular...
  Cassandra Doyno
• Systematic Review of mHealth Applications That Interface with Inhaler Sensors in Asthma September 11, 2020
  CONCLUSIONS: The current literature evaluating mHealth apps paired with inhaler-based sensors focuses on a small number of available products and has limitations in quality. Positive effects on rescue inhaler use, inhaler adherence, and patient satisfaction were found. However, more comprehensive evaluation of products and their impact on health outcomes is needed before clinicians and patients […]
  Elaine Nguyen
• Real-world management of oral factor Xa inhibitor-related bleeds with reversal or replacement agents including andexanet alfa and four-factor prothrombin complex concentrate: a multicenter study July 4, 2020
  Aim: We describe the real-world utilization and outcomes associated with managing oral factor Xa inhibitor (FXai)-related major bleeds. Materials & methods: Electronic records from 45 US hospitals were queried (ICD-10-CM billing codes D68.32, T45.515x or T45.525x) to identify major bleed hospitalizations related to FXai use. Patient demographics, bleed type (intracranial hemorrhage, gastrointestinal, critical compartment, traumatic, […]
  Craig I Coleman
• Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data June 27, 2020
  There is limited data evaluating clinical outcomes of rivaroxaban versus warfarin in obese patients with venous thromboembolism (VTE). Our objective was to evaluate the effectiveness and safety of rivaroxaban versus warfarin in obese VTE patients. We performed a cohort analysis using Optum® De-Identified Electronic Health Record data from 11/1/2012 to 9/30/2018. Patients with a body […]
  Olivia S Costa
• Short-term efficacy of umbilical cord milking in preterm infants: systematic review and meta-analysis April 22, 2020
  CONCLUSIONS: UCM did not decrease short-term clinical outcomes in comparison to ICC or DCC in preterm infants. Intermediate outcomes improved significantly with UCM.
  Joshuan J Barboza